Cytochrome P450-2C11 mRNA is not expressed in endothelial cells dissected from rat renal arterioles

Nephron - Physiology

Volumn 99, Issue 2, 2005, Pages

  Heil, Sandra G ^a   De Vriese, An S ^b   Kluijtmans, Leo A J ^a   Dijkman, Henry ^a   Van Strien, Denise ^a   Akkers, Robert ^a   Blom, Henk J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cytochrome P450 2C11; Endothelium derived hyperpolarizing factor; Laser microdissection; Polymerase chain reaction, real time quantitative

Indexed keywords

CYTOCHROME P450 2C11; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; MESSENGER RNA; RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENDER; KIDNEY CELL; LASER MICRODISSECTION; LIVER; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; RENAL ARTERY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION;

ANIMALS; ARTERIOLES; ARYL HYDROCARBON HYDROXYLASES; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; KIDNEY; MALE; RATS; RATS, WISTAR; RNA, MESSENGER; STEROID 16-ALPHA-HYDROXYLASE;

EID: 13244298531     PISSN: 16602137     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083135     Document Type: Article

References (29)

1. Feletou M, Vanhoutte PM: The third pathway: Endothelium-dependent hyperpolarization. J Physiol Pharmacol 1999;50:525-534.
2. Shimokawa H, Yasutake H, Fujii K, Owada MK, Nakaike R, Fukumoto Y, Takayanagi T, Nagao T, Egashira K, Fujishima M, Takeshita A: The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol 1996;28:703-711.
3. Quilley J, Fulton D, McGiff JC: Hyperpolarizing factors. Biochem Pharmacol 1997;54: 1059-1070.
4. Busse R, Edwards G, Feletou M, Fleming I, Vanhoutte PM, Weston AH: EDHF: Bringing the concepts together. Trends Pharmacol Sci 2002;23:374-380.
5. Campbell WB, Gebremedhin D, Pratt PF, Harder DR: Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 1996;78:415-423.
6. Imig JD, Navar LG, Roman RJ, Reddy KK, Falck JR: Actions of epoxygenase metabolites on the preglomerular vasculature. J Am Soc Nephrol 1996;7:2364-2370.
7. Fleming I: Cytochrome P450 epoxygenases as EDHF synthase(s). Pharmacol Res 2004;49:525-533.
8. De Vriese AS, Van D, V, Blom HJ, Vanhoutte PM, Verbeke M, Lameire NH: The impaired renal vasodilator response attributed to endothelium-derived hyperpolarizing factor in streptozotocin-induced diabetic rats is restored by 5-methyltetrahydrofolate. Diabetologia 2000;43:1116-1125.
9. De Vriese AS, Blom HJ, Heil SG, Mortier S, Kluijtmans LA, Van D, V, Lameire NH: Endothelium-derived hyperpolarizing factor-mediated renal vasodilatory response is impaired during acute and chronic hyperhomocysteinemia. Circulation 2004;109:2331-2336.
10. Holla VR, Makita K, Zaphiropoulos PG, Capdevila JH: The kidney cytochrome P-450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading. J Clin Invest 1999;104:751-760.
11. Baugh LR, Hill AA, Brown EL, Hunter CP: Quantitative analysis of mRNA amplification by in vitro transcription. Nucleic Acids Res 2001;29:e29.
12. Bustin SA: Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000;25:169-193.
13. Wittliff JL, Erlander MG: Laser capture microdissection and its applications in genomics and proteomics. Methods Enzymol 2002;356:12-25.
14. Lahr G, Starzinski-Powitz A, Mayer A: Analysis of specific gene expression. Methods Enzymol 2002;356:271-281.
15. Willenberg HS, Walters R, Bornstein SR: Use of laser microdissection in complex tissue. Methods Enzymol 2002;356:216-223.
16. Archer SL, Gragasin FS, Wu X, Wang S, McMurtry S, Kim DH, Platonov M, Koshal A, Hashimoto K, Campbell WB, Falck JR, Michelakis ED: Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12- epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels. Circulation 2003;107:769-776.
17. Stagliano NE, Carpino AJ, Ross JS, Donovan M: Vascular gene discovery using laser capture microdissection of human blood vessels and quantitative PCR. Ann NY Acad Sci 2001;947:344-349.
18. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, Busse R: Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 1999;401:493-497.
19. Bolz SS, Fisslthaler B, Pieperhoff S, De Wit C, Fleming I, Busse R, Pohl U: Antisense oligonucleotides against cytochrome P450 2C8 attenuate EDHF-mediated Ca(2+) changes and dilation in isolated resistance arteries. FASEB J 2000;14:255-260.
20. Fisslthaler B, Hinsch N, Chataigneau T, Popp R, Kiss L, Busse R, Fleming I: Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factormediated responses in coronary arteries. Hypertension 2000;36:270-275.
21. Passauer J, Bussemaker E, Lassig G, Pistrosch F, Fauler J, Gross P, Fleming I: Baseline blood flow and bradykinin-induced vasodilator responses in the human forearm are insensitive to the cytochrome P450 2C9 (CYP2C9) inhibitor sulphaphenazole. Clin Sci (Lond) 2003;105:513-518.
22. Fukao M, Hattori Y, Kanno M, Sakuma I, Kitabatake A: Evidence against a role of cytochrome P450-derived arachidonic acid metabolites in endothelium-dependent hyperpolarization by acetylcholine in rat isolated mesenteric artery. Br J Pharmacol 1997;120:439-446.
23. Zhao X, Pollock DM, Zeldin DC, Imig JD: Salt-sensitive hypertension after exposure to angiotensin is associated with inability to upregulate renal epoxygenases. Hypertension 2003;42:775-780.
24. Zhao X, Pollock DM, Inscho EW, Zeldin DC, Imig JD: Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with angiotensin salt-sensitive hypertension. Hypertension 2003;41:709-714.
25. Waxman DJ: Rat hepatic cytochrome P-450 isoenzyme 2c. Identification as a male-specific, developmentally induced steroid 16 alpha-hydroxylase and comparison to a female-specific cytochrome P-450 isoenzyme. J Biol Chem 1984;259:15481-15490.
26. Yoshioka H, Morohashi K, Sogawa K, Miyata T, Kawajiri K, Hirose T, Inayama S, Fujii-Kuriyama Y, Omura T: Structural analysis and specific expression of microsomal cytochrome P-450(M-1) mRNA in male rat livers. J Biol Chem 1987;262:1706-1711.
27. Sakuma T, Masaki K, Itoh S, Yokoi T, Kamataki T: Sex-related differences in the expression of cytochrome P450 in hamsters: cDNA cloning and examination of the expression of three distinct CYP2C cDNAs. Mol Pharmacol 1994;45:228-236.
28. Omata K, Abraham NG, Escalante B, Schwartzman ML: Age-related changes in renal cytochrome P-450 arachidonic acid metabolism in spontaneously hypertensive rats. Am J Physiol 1992;262:F8-F16.
29. Pomposiello SI, Carroll MA, Falck JR, McGiff JC: Epoxyeicosatrienoic acid-mediated renal vasodilation to arachidonic acid is enhanced in SHR. Hypertension 2001;37:887-893.